skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,703  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)
Material Type:
Article
Add to My Research

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)

Clinical ophthalmology (Auckland, N.Z.), 2017-01, Vol.11, p.393-401 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Blinder et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/opth.s128509 ;PMID: 28260851

Full text available

2
Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study
Material Type:
Article
Add to My Research

Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study

Clinical ophthalmology (Auckland, N.Z.), 2015-01, Vol.9 (default), p.1255-1268 [Peer Reviewed Journal]

COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015 Lam et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S80500 ;PMID: 26203215

Full text available

3
Faricimab for Treatment-Resistant Diabetic Macular Edema
Material Type:
Article
Add to My Research

Faricimab for Treatment-Resistant Diabetic Macular Edema

Clinical ophthalmology (Auckland, N.Z.), 2022-08, Vol.16, p.2797-2801 [Peer Reviewed Journal]

COPYRIGHT 2022 Dove Medical Press Limited ;2022. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Rush and Rush. 2022 Rush and Rush. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S381503 ;PMID: 36042912

Full text available

4
Cystoid macular edema
Material Type:
Article
Add to My Research

Cystoid macular edema

Clinical ophthalmology (Auckland, N.Z.), 2008-12, Vol.2 (4), p.919-930 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Rotsos and Moschos, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S4033 ;PMID: 19668445

Full text available

5
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
Material Type:
Article
Add to My Research

Dexamethasone intravitreal implant in the treatment of diabetic macular edema

Clinical ophthalmology (Auckland, N.Z.), 2015-01, Vol.9 (default), p.1321-1335 [Peer Reviewed Journal]

COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015 Dugel et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S79948 ;PMID: 26213460

Full text available

6
Treatment of Diabetic Macular Edema with Aflibercept and Micropulse Laser (DAM Study)
Material Type:
Article
Add to My Research

Treatment of Diabetic Macular Edema with Aflibercept and Micropulse Laser (DAM Study)

Clinical ophthalmology (Auckland, N.Z.), 2022-04, Vol.16, p.1109-1115 [Peer Reviewed Journal]

2022 Koushan et al. ;COPYRIGHT 2022 Dove Medical Press Limited ;2022 Koushan et al. 2022 Koushan et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S360869 ;PMID: 35422607

Full text available

7
Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)
Material Type:
Article
Add to My Research

Real-World Outcomes in Patients with Diabetic Macular Edema Treated Long Term with Ranibizumab (VISION Study)

Clinical ophthalmology (Auckland, N.Z.), 2020-01, Vol.14, p.4173-4185 [Peer Reviewed Journal]

2020 Van Aken et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Van Aken et al. 2020 Van Aken et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S281501 ;PMID: 33299294

Full text available

8
Treatment of Diabetic Macular Edema or Macular Edema Following Retinal Vein Occlusion Based on Repeated Injection of the Dexamethasone Intravitreal Implant: A Retrospective Real-World Analysis
Material Type:
Article
Add to My Research

Treatment of Diabetic Macular Edema or Macular Edema Following Retinal Vein Occlusion Based on Repeated Injection of the Dexamethasone Intravitreal Implant: A Retrospective Real-World Analysis

Clinical ophthalmology (Auckland, N.Z.), 2023-10, Vol.17, p.3177-3187 [Peer Reviewed Journal]

COPYRIGHT 2023 Dove Medical Press Limited ;2023 Sanders et al. 2023 Sanders et al. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S402142

Full text available

9
Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema
Material Type:
Article
Add to My Research

Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema

Clinical ophthalmology (Auckland, N.Z.), 2013-01, Vol.7 (default), p.1423-1428 [Peer Reviewed Journal]

2013. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Pacella et al, publisher and licensee Dove Medical Press Ltd 2013 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S48364 ;PMID: 23901252

Full text available

10
Dexamethasone implant in the management of diabetic macular edema from clinician's perspective
Material Type:
Article
Add to My Research

Dexamethasone implant in the management of diabetic macular edema from clinician's perspective

Clinical ophthalmology (Auckland, N.Z.), 2019-05, Vol.13, p.829-840 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019 Urbančič and Gardašević Topčić. 2019 Urbančič and Gardašević Topčić ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S206769 ;PMID: 31190726

Full text available

11
Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN ® ) and Follow-Up Considerations/Recommendations
Material Type:
Article
Add to My Research

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN ® ) and Follow-Up Considerations/Recommendations

Clinical ophthalmology (Auckland, N.Z.), 2020-01, Vol.14, p.2091-2107 [Peer Reviewed Journal]

COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Adán et al. 2020 Adán et al. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S252359 ;PMID: 32801618

Full text available

12
Challenges in Diabetic Macular Edema Management: An Expert Consensus Report
Material Type:
Article
Add to My Research

Challenges in Diabetic Macular Edema Management: An Expert Consensus Report

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.3183-3195 [Peer Reviewed Journal]

COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Udaondo et al. 2021 Udaondo et al. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S320948 ;PMID: 34349495

Full text available

13
Subfoveal choroidal thickness in diabetic macular edema
Material Type:
Article
Add to My Research

Subfoveal choroidal thickness in diabetic macular edema

Clinical ophthalmology (Auckland, N.Z.), 2019-01, Vol.13, p.921-925 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019 Mohamed et al. 2019 Mohamed et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S207376 ;PMID: 31213763

Full text available

14
Update on corticosteroids for diabetic macular edema
Material Type:
Article
Add to My Research

Update on corticosteroids for diabetic macular edema

Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10, p.1723-1730 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Schwartz et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S115546 ;PMID: 27660409

Full text available

15
Intravitreal bevacizumab injections for diabetic macular edema - predictors of response: a retrospective study
Material Type:
Article
Add to My Research

Intravitreal bevacizumab injections for diabetic macular edema - predictors of response: a retrospective study

Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10, p.2093-2098 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Joshi et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S109809 ;PMID: 27799737

Full text available

16
Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges
Material Type:
Article
Add to My Research

Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges

Clinical ophthalmology (Auckland, N.Z.), 2019-09, Vol.13, p.1761-1777 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Massa et al. 2019 Massa et al. ;ISSN: 1177-5483 ;ISSN: 1177-5467 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S180580 ;PMID: 31571815

Full text available

17
Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
Material Type:
Article
Add to My Research

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis

Clinical ophthalmology (Auckland, N.Z.), 2021-01, Vol.15, p.253-260 [Peer Reviewed Journal]

2021 Pessoa et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Pessoa et al. 2021 Pessoa et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S280644 ;PMID: 33519187

Full text available

18
Role of Intravitreal Dexamethasone Implant in the Management of Treatment-Naive Diabetic Macular Edema: A Pre-Cataract Surgical Approach for Patients with Systemic Contraindications to Anti-VEGF Therapy
Material Type:
Article
Add to My Research

Role of Intravitreal Dexamethasone Implant in the Management of Treatment-Naive Diabetic Macular Edema: A Pre-Cataract Surgical Approach for Patients with Systemic Contraindications to Anti-VEGF Therapy

Clinical ophthalmology (Auckland, N.Z.), 2024-01, Vol.18, p.227-233 [Peer Reviewed Journal]

2024 Chakraborty et al. ;COPYRIGHT 2024 Dove Medical Press Limited ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S449250 ;PMID: 38283181

Full text available

19
A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome
Material Type:
Article
Add to My Research

A Real-World Study of Dexamethasone Implant in Treatment-Naïve Patients with Diabetic Macular Edema: Efficacy and Correlation Between Inflammatory Biomarkers and Treatment Outcome

Clinical ophthalmology (Auckland, N.Z.), 2020-01, Vol.14, p.2657-2665 [Peer Reviewed Journal]

2020 Vadalà et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Vadalà et al. 2020 Vadalà et al. ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S257775 ;PMID: 32982158

Full text available

20
Population pharmacokinetics of pegaptanib sodium (Macugen(®)) in patients with diabetic macular edema
Material Type:
Article
Add to My Research

Population pharmacokinetics of pegaptanib sodium (Macugen(®)) in patients with diabetic macular edema

Clinical ophthalmology (Auckland, N.Z.), 2015-01, Vol.9 (default), p.323-335 [Peer Reviewed Journal]

COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Basile et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1177-5467 ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S74050 ;PMID: 25733800

Full text available

Results 1 - 20 of 1,703  for All Library Resources

Results 1 2 3 4 5 next page

Searching Remote Databases, Please Wait